215 related articles for article (PubMed ID: 27750106)
1. Breast cancer osteomimicry and its role in bone specific metastasis; an integrative, systematic review of preclinical evidence.
Awolaran O; Brooks SA; Lavender V
Breast; 2016 Dec; 30():156-171. PubMed ID: 27750106
[TBL] [Abstract][Full Text] [Related]
2. miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes.
Croset M; Pantano F; Kan CWS; Bonnelye E; Descotes F; Alix-Panabières C; Lecellier CH; Bachelier R; Allioli N; Hong SS; Bartkowiak K; Pantel K; Clézardin P
Cancer Res; 2018 Sep; 78(18):5259-5273. PubMed ID: 30042152
[TBL] [Abstract][Full Text] [Related]
3. Patterns of metastatic spread in early breast cancer.
Klevesath MB; Pantel K; Agbaje O; Provenzano E; Wishart GC; Gough P; Pinder SE; Duffy S; Purushotham AD
Breast; 2013 Aug; 22(4):449-54. PubMed ID: 23726130
[TBL] [Abstract][Full Text] [Related]
4. Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers.
Kruger TE; Miller AH; Godwin AK; Wang J
Crit Rev Oncol Hematol; 2014 Feb; 89(2):330-41. PubMed ID: 24071501
[TBL] [Abstract][Full Text] [Related]
5. Enpp1: a potential facilitator of breast cancer bone metastasis.
Lau WM; Doucet M; Stadel R; Huang D; Weber KL; Kominsky SL
PLoS One; 2013; 8(7):e66752. PubMed ID: 23861746
[TBL] [Abstract][Full Text] [Related]
6. Osteoactivin promotes breast cancer metastasis to bone.
Rose AA; Pepin F; Russo C; Abou Khalil JE; Hallett M; Siegel PM
Mol Cancer Res; 2007 Oct; 5(10):1001-14. PubMed ID: 17951401
[TBL] [Abstract][Full Text] [Related]
7. Identification of prospective factors promoting osteotropism in breast cancer: a potential role for CITED2.
Lau WM; Weber KL; Doucet M; Chou YT; Brady K; Kowalski J; Tsai HL; Yang J; Kominsky SL
Int J Cancer; 2010 Feb; 126(4):876-84. PubMed ID: 19642106
[TBL] [Abstract][Full Text] [Related]
8. Bone sialoprotein-αvβ3 integrin axis promotes breast cancer metastasis to the bone.
Wang L; Song L; Li J; Wang Y; Yang C; Kou X; Xiao B; Zhang W; Li L; Liu S; Wang J
Cancer Sci; 2019 Oct; 110(10):3157-3172. PubMed ID: 31432600
[TBL] [Abstract][Full Text] [Related]
9. CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone.
Ouellet V; Tiedemann K; Mourskaia A; Fong JE; Tran-Thanh D; Amir E; Clemons M; Perbal B; Komarova SV; Siegel PM
Am J Pathol; 2011 May; 178(5):2377-88. PubMed ID: 21514448
[TBL] [Abstract][Full Text] [Related]
10. CCN3/Nephroblastoma Overexpressed Is a Functional Mediator of Prostate Cancer Bone Metastasis That Is Associated with Poor Patient Prognosis.
Dankner M; Ouellet V; Communal L; Schmitt E; Perkins D; Annis MG; Barrès V; Caron C; Mes-Masson AM; Saad F; Siegel PM;
Am J Pathol; 2019 Jul; 189(7):1451-1461. PubMed ID: 31202437
[TBL] [Abstract][Full Text] [Related]
11. TWIST1 expression in breast cancer cells facilitates bone metastasis formation.
Croset M; Goehrig D; Frackowiak A; Bonnelye E; Ansieau S; Puisieux A; Clézardin P
J Bone Miner Res; 2014 Aug; 29(8):1886-99. PubMed ID: 24619707
[TBL] [Abstract][Full Text] [Related]
12. CITED2 Modulates Breast Cancer Metastatic Ability through Effects on IKKα.
Jayaraman S; Doucet M; Lau WM; Kominsky SL
Mol Cancer Res; 2016 Aug; 14(8):730-9. PubMed ID: 27216153
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.
Shimo T; Kubota S; Yoshioka N; Ibaragi S; Isowa S; Eguchi T; Sasaki A; Takigawa M
J Bone Miner Res; 2006 Jul; 21(7):1045-59. PubMed ID: 16813525
[TBL] [Abstract][Full Text] [Related]
14. The Role of Cytokines in the Metastasis of Solid Tumors to the Spine: Systematic Review.
Łabędź W; Przybyla A; Zimna A; Dąbrowski M; Kubaszewski Ł
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835198
[TBL] [Abstract][Full Text] [Related]
15. Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells.
Nam JS; Kang MJ; Suchar AM; Shimamura T; Kohn EA; Michalowska AM; Jordan VC; Hirohashi S; Wakefield LM
Cancer Res; 2006 Jul; 66(14):7176-84. PubMed ID: 16849564
[TBL] [Abstract][Full Text] [Related]
16. CCN3 promotes prostate cancer bone metastasis by modulating the tumor-bone microenvironment through RANKL-dependent pathway.
Chen PC; Cheng HC; Tang CH
Carcinogenesis; 2013 Jul; 34(7):1669-79. PubMed ID: 23536580
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma.
Carlinfante G; Vassiliou D; Svensson O; Wendel M; Heinegård D; Andersson G
Clin Exp Metastasis; 2003; 20(5):437-44. PubMed ID: 14524533
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin as a multifaceted driver of bone metastasis and drug resistance.
Pang X; Gong K; Zhang X; Wu S; Cui Y; Qian BZ
Pharmacol Res; 2019 Jun; 144():235-244. PubMed ID: 31028902
[TBL] [Abstract][Full Text] [Related]
19. Genes involved in breast cancer metastasis to bone.
Sloan EK; Anderson RL
Cell Mol Life Sci; 2002 Sep; 59(9):1491-502. PubMed ID: 12440771
[TBL] [Abstract][Full Text] [Related]
20. ANGPTL2 increases bone metastasis of breast cancer cells through enhancing CXCR4 signaling.
Masuda T; Endo M; Yamamoto Y; Odagiri H; Kadomatsu T; Nakamura T; Tanoue H; Ito H; Yugami M; Miyata K; Morinaga J; Horiguchi H; Motokawa I; Terada K; Morioka MS; Manabe I; Iwase H; Mizuta H; Oike Y
Sci Rep; 2015 Mar; 5():9170. PubMed ID: 25773070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
